Evaluation of the Abdala Vaccine: Antibody and Cellular Response to the RBD Domain of SARS-CoV-2.

Abdala (CIGB-66) - Center for Genetic Engineering and Biotechnology

http://www.ncbi.nlm.nih.gov/pubmed/38140191

Eduardo Villalobos-Gonzalez; Gloria Ornelas-Hall; Henry Velázquez-Soto; Lorenzo Islas-Vazquez; María C Jiménez-Martínez; Marisa Cruz-Aguilar; Sonia Mayra Pérez-Tapia; Yan Carlos Alvarado-Alvarado

Dec 24, 2023